Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The benefit of anti-worm therapy as part of the case management of severe acute malnutrition (SAM) in the outpatient setting has not previously been studied. This study will compare recovery rates of children with SAM treated in the community with locally-produced ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their case management.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Washington University School of Medicine
• Collaborator: University of Malawi College of Medicine
• Treatments: Albendazole

Criteria

Inclusion Criteria:

• 12-59 months old

• Kwashiorkor and/or Marasmus

• Qualified for home-based therapeutic feeding with RUTF

Exclusion Criteria:

• Obvious congenital or other malformation that makes child a poor candidate for feeding with RUTF

• Unable to consume test-dose of RUTF in clinic

• Parent refusal to participate and return for follow-up